Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-24-050413

President sold 4,000 shares at an average $12.10 ($48,399)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ma Songjiang · President

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-23 Sale : show line 1 in the form 10b5-1 −1,704 $12.24 $20,857 2,932,763 I
2024-12-23 Sale : show line 2 in the form 10b5-1 −296 $12.44 $3,682 2,932,467 I
2024-12-24 Sale : show line 3 in the form 10b5-1 −2,000 $11.93 $23,860 2,930,467 I
Open-market sales · 4,000 sh · avg $12.10 · $48,399
Loading xslF345X05/form4.xml…